Ovid Therapeutics Inc.
Total Trades
8
Buys
2
Sells
5
Largest Trade
N/A
Insiders
4
Institutional Funds
61
Inst. Value
$1M+
Activist Filings
29
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ALEXANDER MARGARET A. | President and CEO | SELL | $15K–$50K | 12K | $1.45 | Mar 2, 2026 |
| Rona Jeffrey A | CBFO | SELL | $1K–$15K | 9K | $1.45 | Mar 2, 2026 |
| Rona Jeffrey A | CBFO | GRANT | N/A | 68K | — | Mar 2, 2026 |
| ALEXANDER MARGARET A. | President and COO | SELL | $1K–$15K | 5K | $0.56 | Feb 28, 2025 |
| Rona Jeffrey A | CBFO | SELL | $1K–$15K | 4K | $0.56 | Feb 28, 2025 |
| ALEXANDER MARGARET A. | President and COO | BUY | $1K–$15K | 7K | $0.73 | Jan 29, 2025 |
| LEVIN JEREMY M | CEO | BUY | $50K–$100K | 18K | $2.76 | Mar 20, 2024 |
| Tardio Jason | COO | SELL | $15K–$50K | 17K | $2.15 | Sep 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 61 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.7M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 7.2M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 4.3M | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 4.3M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 4.3M | $1M+ | SH |
| Point72 Asset Management, L.P. | 3.6M | $1M+ | SH |
| FEDERATED HERMES, INC. | 3.6M | $1M+ | SH |
| Ally Bridge Group (NY) LLC | 1.8M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.5M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 1.2M | $1M+ | SH |
| AWM Investment Company, Inc. | 899K | $1M+ | SH |
| WELLS FARGO & COMPANY/MN | 721K | $1M+ | SH |
| JANE STREET GROUP, LLC | 650K | $1M+ | SH |
| Assenagon Asset Management S.A. | 618K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 550K | $500K+ | SH |
| Walleye Capital LLC | 530K | $500K+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 325K | $500K+ | SH |
| STATE STREET CORP | 277K | $100K–$500K | SH |
| Ikarian Capital, LLC | 248K | $100K–$500K | SH |
| TLS Advisors LLC | 14K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 18, 2026
6.9%
9.3M shares
SC 13G/A · Jan 30, 2026
9.0%
12.1M shares
SC 13G · Jan 8, 2026
5.9%
7.7M shares
Point72 Asset Management, L.P.
SC 13G · Jan 5, 2026
5.1%
6.7M shares
SC 13G · Dec 18, 2025
9.9%
13.3M shares
SC 13G · Dec 18, 2025
9.0%
12.1M shares
Takeda Pharmaceutical Company Limited
SC 13G/A · Dec 10, 2025
12.3%
8.8M shares
SC 13G · Dec 8, 2025
10.0%
7.1M shares
SC 13G/A · Jul 21, 2025
0.0%
0 shares
SC 13G/A · Jul 18, 2025
1.9%
1.4M shares
SC 13G/A · Jul 9, 2025
0.7%
479K shares
SC 13G/A · Feb 14, 2025
4.0%
2.9M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
2.8%
2.0M shares
SC 13G/A · Feb 14, 2024
9.4%
6.9M shares
Madison Avenue International LP
SC 13G/A · Feb 14, 2024
5.2%
3.6M shares
SC 13G/A · Feb 12, 2024
7.5%
5.3M shares
SC 13G · Jan 29, 2024
6.1%
4.3M shares
Madison Avenue International LP
SC 13G · Jul 31, 2023
5.1%
3.6M shares
SC 13G/A · Feb 14, 2023
10.0%
7.3M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 13, 2023
5.2%
3.6M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 13, 2023
0.0%
0 shares
SC 13G · Feb 10, 2023
9.7%
6.8M shares
SC 13G/A · Feb 10, 2023
8.7%
6.1M shares
Takeda Pharmaceutical Company Limited
SC 13G/A · Feb 3, 2023
12.2%
8.8M shares
SC 13G/A · Feb 14, 2022
4.5%
3.1M shares
SC 13G/A · Feb 14, 2022
9.4%
6.6M shares
SC 13G/A · Feb 14, 2022
8.9%
6.1M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 11, 2022
5.9%
4.0M shares